Serge Carillo

1.9k total citations
35 papers, 1.4k citations indexed

About

Serge Carillo is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Serge Carillo has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Genetics and 8 papers in Hematology. Recurrent topics in Serge Carillo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Kruppel-like factors research (7 papers) and Calpain Protease Function and Regulation (6 papers). Serge Carillo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Kruppel-like factors research (7 papers) and Calpain Protease Function and Regulation (6 papers). Serge Carillo collaborates with scholars based in France, United States and Switzerland. Serge Carillo's co-authors include Magali Pariât, Marc Piechaczyk, Curt M. Pfarr, Moshé Yaniv, Fatima Mechta‐Grigoriou, Dominique Lallemand, Isabelle Jariel‐Encontre, Thierry Lavabre‐Bertrand, Laurent Henry and Catherine Salvat and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Blood.

In The Last Decade

Serge Carillo

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serge Carillo France 17 975 331 314 295 285 35 1.4k
Takako Ooshio Japan 16 1.0k 1.1× 170 0.5× 233 0.7× 292 1.0× 283 1.0× 28 1.5k
Marie‐Josèphe Pébusque France 19 994 1.0× 272 0.8× 350 1.1× 110 0.4× 344 1.2× 29 1.6k
Blanca Scheijen Netherlands 24 1.5k 1.6× 282 0.9× 615 2.0× 188 0.6× 566 2.0× 53 2.6k
Nadine Varin‐Blank France 30 947 1.0× 420 1.3× 349 1.1× 261 0.9× 195 0.7× 65 2.0k
Jana Karásková Canada 17 870 0.9× 248 0.7× 379 1.2× 116 0.4× 147 0.5× 22 1.4k
Haipeng Shao United States 21 595 0.6× 237 0.7× 319 1.0× 163 0.6× 91 0.3× 40 1.3k
Paulo De Sepulveda France 22 726 0.7× 233 0.7× 548 1.7× 201 0.7× 289 1.0× 37 1.7k
Elspeth M. Beauchamp United States 18 1.1k 1.1× 141 0.4× 288 0.9× 118 0.4× 137 0.5× 32 1.5k
Samuel D. Foster United Kingdom 8 980 1.0× 232 0.7× 157 0.5× 263 0.9× 407 1.4× 8 1.4k
Jyh-Rong Chao United States 8 823 0.8× 179 0.5× 367 1.2× 113 0.4× 98 0.3× 9 1.2k

Countries citing papers authored by Serge Carillo

Since Specialization
Citations

This map shows the geographic impact of Serge Carillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Carillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Carillo more than expected).

Fields of papers citing papers by Serge Carillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Carillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Carillo. The network helps show where Serge Carillo may publish in the future.

Co-authorship network of co-authors of Serge Carillo

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Carillo. A scholar is included among the top collaborators of Serge Carillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Carillo. Serge Carillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carillo, Serge, et al.. (2025). EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability. British Journal of Haematology. 206(2). 721–725.
2.
Verger, Emmanuelle, Bruno Cassinat, Aurélie Chauveau, et al.. (2015). Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations. Blood. 126(24). 2585–2591. 109 indexed citations
3.
Park, Ji‐Hye, M. Courtois, François Bailly, et al.. (2015). Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods. PLoS ONE. 10(10). e0141010–e0141010. 9 indexed citations
4.
Broséus, Julien, Ji‐Hye Park, Serge Carillo, Sylvie Hermouet, & François Girodon. (2014). Presence of calreticulin mutations in JAK2-negative polycythemia vera. Blood. 124(26). 3964–3966. 68 indexed citations
5.
Girodon, François, Éric Lippert, Sylvie Hermouet, & Serge Carillo. (2013). High-Resolution Melting (HRM) Curve Analysis Is a Reliable and Relevant Tool In JAK2V617F-Negative Myeloproliferative Neoplasms. Blood. 122(21). 4077–4077. 8 indexed citations
6.
Carillo, Serge, Laurent Henry, Éric Lippert, et al.. (2011). Nested High-Resolution Melting Curve Analysis. Journal of Molecular Diagnostics. 13(3). 263–270. 28 indexed citations
7.
Porret, Naomi, Elisabeth Oppliger Leibundgut, Serge Carillo, et al.. (2011). Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study,. Blood. 118(21). 3859–3859. 1 indexed citations
8.
Girodon, François, Céline Schaeffer, Morgane Mounier, et al.. (2009). Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 94(6). 865–869. 35 indexed citations
9.
Henry, Laurent, Thierry Lavabre‐Bertrand, José Ramos, et al.. (2009). Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Gut. 58(6). 833–838. 31 indexed citations
10.
Henry, Laurent, Christophe Delfour, Anne Arnaud, et al.. (2008). Association of Familial Pernicious Anaemia and Hereditary Haemochromatosis. Acta Haematologica. 119(1). 12–14. 3 indexed citations
11.
Lavabre‐Bertrand, Thierry, et al.. (2005). High plasma proteasome levels are detected in patients with metastatic malignant melanoma. British Journal of Dermatology. 152(5). 948–953. 67 indexed citations
12.
Lavabre‐Bertrand, Thierry, José Ramos, Christophe Delfour, et al.. (2004). Long‐term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I. European Journal Of Haematology. 73(5). 380–383. 26 indexed citations
13.
Lavabre‐Bertrand, Thierry, et al.. (2001). Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer. 92(10). 2493–2500. 93 indexed citations
14.
Salvat, Catherine, Isabelle Jariel‐Encontre, Patrizia Ferrara, et al.. (1999). Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?. Molecular Biology Reports. 26(1-2). 45–51. 48 indexed citations
15.
Pariât, Magali, Serge Carillo, Marta Molinari, et al.. (1997). Proteolysis by Calpains: a Possible Contribution to Degradation of p53. Molecular and Cellular Biology. 17(5). 2806–2815. 138 indexed citations
16.
Steff, Ann‐Muriel, Serge Carillo, Magali Pariât, & Marc Piechaczyk. (1997). Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts. Biochemical Journal. 323(3). 685–692. 8 indexed citations
17.
Carillo, Serge, Magali Pariât, Ann‐Muriel Steff, et al.. (1996). PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. Biochemical Journal. 313(1). 245–251. 43 indexed citations
18.
Jariel‐Encontre, Isabelle, et al.. (1995). Ubiquitinylation Is Not an Absolute Requirement for Degradation of c-Jun Protein by the 26 S Proteasome. Journal of Biological Chemistry. 270(19). 11623–11627. 128 indexed citations
19.
Carillo, Serge, Magali Pariât, Isabelle Jariel‐Encontre, Ann‐Muriel Steff, & Martine Piechaczyk. (1995). Le catabolisme protéique intracellulaire : une fonction biologique majeure. Partie I : les mécanismes de dégradation.. médecine/sciences. 11(5). 723–723.
20.
Pfarr, Curt M., et al.. (1994). Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell. 76(4). 747–760. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026